Literature DB >> 8057103

Serum concentrations of 2',5'-oligoadenylate synthetase, neopterin, and beta-glucan in patients with chronic fatigue syndrome and in patients with major depression.

J Matsuda, K Gohchi, N Gotoh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8057103      PMCID： PMC1073106          DOI： 10.1136/jnnp.57.8.1015-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

2.  Chronic fatigue syndrome and depression.

Authors:  I Hickie; A Lloyd; D Wakefield
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

3.  Increased (2'-5')-oligo-A synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection.

Authors:  A Morag; M Tobi; Z Ravid; M Revel; A Schattner
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

4.  Myalgic encephalomyelitis and alpha-interferon.

Authors:  D O Ho-Yen; D Carrington; A A Armstrong
Journal:  Lancet       Date:  1988-01-16       Impact factor: 79.321

5.  Depression and somatization in the chronic fatigue syndrome.

Authors:  T J Lane; P Manu; D A Matthews
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965
  5 in total
  1 in total

Review 1.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.